MYASTHENIA GRAVIS, GENERALIZED
Clinical trials for MYASTHENIA GRAVIS, GENERALIZED explained in plain language.
Never miss a new study
Get alerted when new MYASTHENIA GRAVIS, GENERALIZED trials appear
Sign up with your email to follow new studies for MYASTHENIA GRAVIS, GENERALIZED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare muscle disease: drug trial targets patients standard treatments miss
Disease control OngoingThis study tests an investigational drug called efgartigimod in adults with generalized myasthenia gravis (gMG) who do not have the typical acetylcholine receptor antibodies. The trial compares the drug to a placebo to see if it improves daily activities and muscle strength. Abou…
Matched conditions: MYASTHENIA GRAVIS, GENERALIZED
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated May 15, 2026 12:07 UTC
-
New drug trial aims to ease muscle weakness in myasthenia gravis
Disease control OngoingThis study tests an experimental drug called DNTH103 in 65 adults with generalized myasthenia gravis, a condition causing muscle weakness. Participants receive either the drug or a placebo to see if it safely improves daily activities like talking, swallowing, and breathing. The …
Matched conditions: MYASTHENIA GRAVIS, GENERALIZED
Phase: PHASE2 • Sponsor: Dianthus Therapeutics • Aim: Disease control
Last updated May 11, 2026 20:39 UTC